首页 > 最新文献

Rambam Maimonides Medical Journal最新文献

英文 中文
Against Over-reliance on PRISMA Guidelines for Meta-analytical Studies. 反对过度依赖《元分析研究 PRISMA 指南》。
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-01-19 DOI: 10.5041/RMMJ.10518
Jaime A Teixeira da Silva, Timothy Daly

The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were elaborated to allow authors of such papers to identify quality articles for inclusion in their scholarly work. However, we have identified several issues that point to an over-reliance on the PRISMA guidelines. Firstly, we question the rigor of implementation by authors and the rigor of verification by peer reviewers and editors, and whether they have screened papers to ensure adherence to the PRISMA guidelines. Secondly, we have identified cases where the PRISMA criteria led to as much as 99.97% of the published literature being ignored, suggesting that valid publications meeting these criteria might be at risk of being ignored. Thirdly, we have noted that exclusion is not only a quantitative problem-it is also a qualitative one, since the screening procedure groups all non-conforming literature into one basket. Fourthly, we have noted that seven copies of the PRISMA guidelines exist. This being the case, which one should be cited? To replace over-reliance on PRISMA screening, we encourage authors, peer reviewers, and editors to publish systematic reviews and meta-analyses that respect the dual criteria of scientific plausibility and diversity of included papers.

系统综述和元分析首选报告项目(PRISMA)指南的制定是为了让此类论文的作者能够确定高质量的文章,以便纳入其学术著作。然而,我们发现了几个问题,表明对 PRISMA 指南的过度依赖。首先,我们质疑作者执行的严谨性以及同行评审员和编辑核查的严谨性,质疑他们是否对论文进行了筛选以确保遵守 PRISMA 指南。其次,我们发现在一些案例中,PRISMA 标准导致高达 99.97% 的已发表文献被忽略,这表明符合这些标准的有效出版物可能面临被忽略的风险。第三,我们注意到,排除不仅是一个量的问题,也是一个质的问题,因为筛选程序将所有不符合标准的文献都归到了一个篮子里。第四,我们注意到有七份 PRISMA 指南。既然如此,应该引用哪一份呢?为了取代对 PRISMA 筛选的过度依赖,我们鼓励作者、同行评审员和编辑在发表系统综述和荟萃分析时尊重科学合理性和纳入论文多样性的双重标准。
{"title":"Against Over-reliance on PRISMA Guidelines for Meta-analytical Studies.","authors":"Jaime A Teixeira da Silva, Timothy Daly","doi":"10.5041/RMMJ.10518","DOIUrl":"10.5041/RMMJ.10518","url":null,"abstract":"<p><p>The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were elaborated to allow authors of such papers to identify quality articles for inclusion in their scholarly work. However, we have identified several issues that point to an over-reliance on the PRISMA guidelines. Firstly, we question the rigor of implementation by authors and the rigor of verification by peer reviewers and editors, and whether they have screened papers to ensure adherence to the PRISMA guidelines. Secondly, we have identified cases where the PRISMA criteria led to as much as 99.97% of the published literature being ignored, suggesting that valid publications meeting these criteria might be at risk of being ignored. Thirdly, we have noted that exclusion is not only a quantitative problem-it is also a qualitative one, since the screening procedure groups all non-conforming literature into one basket. Fourthly, we have noted that seven copies of the PRISMA guidelines exist. This being the case, which one should be cited? To replace over-reliance on PRISMA screening, we encourage authors, peer reviewers, and editors to publish systematic reviews and meta-analyses that respect the dual criteria of scientific plausibility and diversity of included papers.</p>","PeriodicalId":46408,"journal":{"name":"Rambam Maimonides Medical Journal","volume":"15 1","pages":""},"PeriodicalIF":1.5,"publicationDate":"2024-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10807856/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139520388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Action Myoclonus Secondary to Donepezil: Case Report and Literature Review. 多奈哌齐继发动作性肌阵挛:病例报告和文献复习。
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-10-29 DOI: 10.5041/RMMJ.10510
Jamir Pitton Rissardo, Ana Letícia Fornari Caprara

Movement disorders associated with donepezil have been only rarely reported. Herein, we describe an older woman who developed myoclonus secondary to donepezil. A 61-year-old female presented with brief involuntary twitching. The patient reported that she consulted a general practitioner about 1 month before due to memory complaints. A diagnosis of mild cognitive impairment was made. Donepezil was started. After 4 weeks, she presented to our emergency department due to significant twitching. Multifocal myoclonus was observed. These movements occurred during rest and voluntary movement. Laboratory exams and cerebrospinal fluid analysis were normal. A cranial computed tomography and brain magnetic resonance imaging were unremarkable. Electroencephalography did not show epileptic activity. Electromyography revealed burst durations varying between 50 and 100 ms. Diazepam intravenous was started, which improved her abnormal movement within 1 hour. On the next day, she developed the same clinical symptoms of presentation. Donepezil was discontinued, and clonazepam was started. The patient had a complete recovery from her myoclonus. To the authors' knowledge, there are six reports of myoclonus secondary to donepezil/galantamine. There is no report of rivastigmine-induced myoclonus. The most frequent presentation was multifocal myoclonus. The management was the discontinuation of the acetylcholinesterase inhibitor. All the individuals recovered within 3 weeks.

与多奈哌齐相关的运动障碍很少被报道。在此,我们描述了一位老年妇女,她发展为多奈哌齐继发性肌阵挛。一名61岁女性出现短暂的不自主抽搐。患者报告称,由于记忆问题,她在大约1个月前咨询了全科医生。诊断为轻度认知障碍。多涅普齐尔开始了。4周后,由于严重抽搐,她出现在我们的急诊科。观察到多灶性肌阵挛。这些运动发生在休息和自愿运动期间。实验室检查和脑脊液分析正常。颅骨计算机断层扫描和脑磁共振成像并不显著。脑电图没有显示癫痫活动。肌电图显示爆裂持续时间在50到100毫秒之间。开始静脉注射安定,这在1小时内改善了她的异常运动。第二天,她出现了同样的临床症状。多奈哌齐停用,氯硝西泮开始使用。病人的肌阵挛完全康复了。据作者所知,有6例多奈哌齐/加兰他敏继发性肌阵挛的报告。目前尚无利瓦斯汀诱发肌阵挛的报告。最常见的表现是多灶性肌阵挛。治疗方法是停用乙酰胆碱酯酶抑制剂。所有个体均在3周内康复。
{"title":"Action Myoclonus Secondary to Donepezil: Case Report and Literature Review.","authors":"Jamir Pitton Rissardo,&nbsp;Ana Letícia Fornari Caprara","doi":"10.5041/RMMJ.10510","DOIUrl":"10.5041/RMMJ.10510","url":null,"abstract":"<p><p>Movement disorders associated with donepezil have been only rarely reported. Herein, we describe an older woman who developed myoclonus secondary to donepezil. A 61-year-old female presented with brief involuntary twitching. The patient reported that she consulted a general practitioner about 1 month before due to memory complaints. A diagnosis of mild cognitive impairment was made. Donepezil was started. After 4 weeks, she presented to our emergency department due to significant twitching. Multifocal myoclonus was observed. These movements occurred during rest and voluntary movement. Laboratory exams and cerebrospinal fluid analysis were normal. A cranial computed tomography and brain magnetic resonance imaging were unremarkable. Electroencephalography did not show epileptic activity. Electromyography revealed burst durations varying between 50 and 100 ms. Diazepam intravenous was started, which improved her abnormal movement within 1 hour. On the next day, she developed the same clinical symptoms of presentation. Donepezil was discontinued, and clonazepam was started. The patient had a complete recovery from her myoclonus. To the authors' knowledge, there are six reports of myoclonus secondary to donepezil/galantamine. There is no report of rivastigmine-induced myoclonus. The most frequent presentation was multifocal myoclonus. The management was the discontinuation of the acetylcholinesterase inhibitor. All the individuals recovered within 3 weeks.</p>","PeriodicalId":46408,"journal":{"name":"Rambam Maimonides Medical Journal","volume":"14 4","pages":""},"PeriodicalIF":1.5,"publicationDate":"2023-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619993/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71427809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cannabis and Rheumatoid Arthritis: A Scoping Review Evaluating the Benefits, Risks, and Future Research Directions. 大麻和类风湿性关节炎:评估益处、风险和未来研究方向的范围综述。
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-10-29 DOI: 10.5041/RMMJ.10509
Nicole Paland, Haya Hamza, Antonina Pechkovsky, Miran Aswad, Dayana Shagidov, Igal Louria-Hayon

Rheumatoid diseases, including rheumatoid arthritis, osteoarthritis, and fibromyalgia, are characterized by progressive inflammation in the musculoskeletal system, predominantly affecting the joints and leading to cartilage and bone damage. The resulting pain and ongoing degradation of the musculoskeletal system contribute to reduced physical activity, ultimately impacting quality of life and imposing a substantial socioeconomic burden. Unfortunately, current therapeutics have limited efficacy in slowing disease progression and managing pain. Thus, the development of novel and alternative therapies is imperative. Cannabinoids possess beneficial properties as potential treatments for rheumatoid diseases due to their anti-inflammatory and analgesic properties. Preclinical studies have demonstrated promising results in halting disease progression and relieving pain. However, there is a scarcity of patient clinical studies, and the available data show mixed results. Consequently, there are currently no established clinical recommendations regarding the utilization of cannabis for treating rheumatoid diseases. In this review, we aim to explore the concept of cannabis use for rheumatoid diseases, including potential adverse effects. We will provide an overview of the data obtained from preclinical and clinical trials and from retrospective studies on the efficacy and safety of cannabis in the treatment of rheumatoid diseases.

类风湿性疾病,包括类风湿性关节炎、骨关节炎和纤维肌痛,其特征是肌肉骨骼系统的进行性炎症,主要影响关节并导致软骨和骨骼损伤。由此产生的疼痛和肌肉骨骼系统的持续退化导致体力活动减少,最终影响生活质量并造成巨大的社会经济负担。不幸的是,目前的治疗方法在减缓疾病进展和控制疼痛方面的疗效有限。因此,开发新的替代疗法势在必行。大麻素由于其抗炎和镇痛特性,作为治疗类风湿性疾病的潜在药物具有有益的特性。临床前研究表明,在阻止疾病进展和缓解疼痛方面取得了有希望的结果。然而,患者临床研究很少,现有数据显示出喜忧参半的结果。因此,目前还没有关于使用大麻治疗类风湿性疾病的既定临床建议。在这篇综述中,我们旨在探讨大麻用于类风湿性疾病的概念,包括潜在的不良反应。我们将概述从大麻治疗类风湿性疾病的疗效和安全性的临床前和临床试验以及回顾性研究中获得的数据。
{"title":"Cannabis and Rheumatoid Arthritis: A Scoping Review Evaluating the Benefits, Risks, and Future Research Directions.","authors":"Nicole Paland,&nbsp;Haya Hamza,&nbsp;Antonina Pechkovsky,&nbsp;Miran Aswad,&nbsp;Dayana Shagidov,&nbsp;Igal Louria-Hayon","doi":"10.5041/RMMJ.10509","DOIUrl":"10.5041/RMMJ.10509","url":null,"abstract":"<p><p>Rheumatoid diseases, including rheumatoid arthritis, osteoarthritis, and fibromyalgia, are characterized by progressive inflammation in the musculoskeletal system, predominantly affecting the joints and leading to cartilage and bone damage. The resulting pain and ongoing degradation of the musculoskeletal system contribute to reduced physical activity, ultimately impacting quality of life and imposing a substantial socioeconomic burden. Unfortunately, current therapeutics have limited efficacy in slowing disease progression and managing pain. Thus, the development of novel and alternative therapies is imperative. Cannabinoids possess beneficial properties as potential treatments for rheumatoid diseases due to their anti-inflammatory and analgesic properties. Preclinical studies have demonstrated promising results in halting disease progression and relieving pain. However, there is a scarcity of patient clinical studies, and the available data show mixed results. Consequently, there are currently no established clinical recommendations regarding the utilization of cannabis for treating rheumatoid diseases. In this review, we aim to explore the concept of cannabis use for rheumatoid diseases, including potential adverse effects. We will provide an overview of the data obtained from preclinical and clinical trials and from retrospective studies on the efficacy and safety of cannabis in the treatment of rheumatoid diseases.</p>","PeriodicalId":46408,"journal":{"name":"Rambam Maimonides Medical Journal","volume":"14 4","pages":""},"PeriodicalIF":1.5,"publicationDate":"2023-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619990/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71427810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Release Our Hostages Now! 立即释放我们的人质!
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-10-29 DOI: 10.5041/RMMJ.10507
Itamar Ashkenazi, Rafael Beyar, Shraga Blazer, Aaron Ciechanover, Karl L Skorecki
{"title":"Release Our Hostages Now!","authors":"Itamar Ashkenazi,&nbsp;Rafael Beyar,&nbsp;Shraga Blazer,&nbsp;Aaron Ciechanover,&nbsp;Karl L Skorecki","doi":"10.5041/RMMJ.10507","DOIUrl":"10.5041/RMMJ.10507","url":null,"abstract":"","PeriodicalId":46408,"journal":{"name":"Rambam Maimonides Medical Journal","volume":"14 4","pages":""},"PeriodicalIF":1.5,"publicationDate":"2023-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619985/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71427814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Uneven Expression of 20 Human Papillomavirus Genes Associated with Oropharyngeal Carcinoma. 20个与口咽癌相关的人乳头瘤病毒基因的不均匀表达。
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-10-29 DOI: 10.5041/RMMJ.10508
Ali Adel Dawood

Background: Human papillomavirus (HPV) is considered to be responsible for 95% of virus-related cancers in many organs. Oropharyngeal carcinoma (OC) is distinguished by the transformation of the healthy epithelium into precancerous cells.

Aim: The current study sought to examine the uneven gene expression of 20 genes among those scanned by microarray for oropharyngeal cancer patients.

Materials and methods: The GSE56142 dataset was extracted from the Gene Expression Omnibus of the National Center for Biotechnology Information; 24 specimens were evaluated. Gene ontology (GO), the Kyoto Encyclopedia of Genes and Genomes, and the protein-protein interaction (PPI) were used to depict the biological roles of the genes under investigation using types of software.

Results: Six genes out of 20 in patients with invasive OC had a binding correlation with high expression (PDGFRS, COL6A3, COL1A1, COL3A1, COL2A1, and COL4A1), and only two genes with low expression (CRCT1 and KRT78). The expression levels of 20 genes were examined for patients with OC versus head and neck squamous cell carcinoma (HNSCC). The correlation coefficient between highly expressed genes of the OC group was statistically significant at the P<0.05 level.

Conclusions: High expression levels of specific genes may serve as diagnostic tumor markers, particularly in the early stages of cancer, and testing should be performed in OC and HNSCC patients.

背景:人类乳头瘤病毒(HPV)被认为是许多器官中95%的病毒相关癌症的原因。口咽癌(OC)的特点是健康上皮转化为癌前细胞。目的:本研究旨在检测癌症患者口咽微阵列扫描的20个基因的不均匀基因表达。材料和方法:GSE56142数据集从国家生物技术信息中心的基因表达综合库中提取;对24个标本进行了评估。基因本体论(GO)、京都基因和基因组百科全书以及蛋白质-蛋白质相互作用(PPI)被用来描述使用各种类型的软件研究的基因的生物学作用。结果:侵袭性OC患者20个基因中有6个与高表达相关(PDGFRS、COL6A3、COL1A1、COL3A1、COL2A1和COL4A1),只有两个基因与低表达相关(CRCT1和KRT78)。检测了OC患者与头颈部鳞状细胞癌(HNSCC)患者20个基因的表达水平。OC组高表达基因之间的相关系数在PC中具有统计学意义。结论:特异性基因的高表达水平可作为诊断肿瘤的标志物,特别是在癌症的早期,应在OC和HNSCC患者中进行检测。
{"title":"Uneven Expression of 20 Human Papillomavirus Genes Associated with Oropharyngeal Carcinoma.","authors":"Ali Adel Dawood","doi":"10.5041/RMMJ.10508","DOIUrl":"10.5041/RMMJ.10508","url":null,"abstract":"<p><strong>Background: </strong>Human papillomavirus (HPV) is considered to be responsible for 95% of virus-related cancers in many organs. Oropharyngeal carcinoma (OC) is distinguished by the transformation of the healthy epithelium into precancerous cells.</p><p><strong>Aim: </strong>The current study sought to examine the uneven gene expression of 20 genes among those scanned by microarray for oropharyngeal cancer patients.</p><p><strong>Materials and methods: </strong>The GSE56142 dataset was extracted from the Gene Expression Omnibus of the National Center for Biotechnology Information; 24 specimens were evaluated. Gene ontology (GO), the Kyoto Encyclopedia of Genes and Genomes, and the protein-protein interaction (PPI) were used to depict the biological roles of the genes under investigation using types of software.</p><p><strong>Results: </strong>Six genes out of 20 in patients with invasive OC had a binding correlation with high expression (PDGFRS, COL6A3, COL1A1, COL3A1, COL2A1, and COL4A1), and only two genes with low expression (CRCT1 and KRT78). The expression levels of 20 genes were examined for patients with OC versus head and neck squamous cell carcinoma (HNSCC). The correlation coefficient between highly expressed genes of the OC group was statistically significant at the P<0.05 level.</p><p><strong>Conclusions: </strong>High expression levels of specific genes may serve as diagnostic tumor markers, particularly in the early stages of cancer, and testing should be performed in OC and HNSCC patients.</p>","PeriodicalId":46408,"journal":{"name":"Rambam Maimonides Medical Journal","volume":"14 4","pages":""},"PeriodicalIF":1.5,"publicationDate":"2023-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619986/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71427816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inappropriate Journal Authorship. 不适当的期刊作者。
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-10-29 DOI: 10.5041/RMMJ.10513
Marshall A Lichtman
In their article “Authorship Disputes in Scholarly Biomedical Publications and Trust in the Research Institution” in the July 2023 issue of RMMJ, Ashkenazi and Olsha examined the association between the prevalence of misattributed authorship and trust in the institution analyzing misconduct in their scholarly publications. The authors, appropriately, include “gift authorship” as one of the three principal deviations from appropriate authorship choices that they examined. In essence, gift or honorary authorship is listing an author on a scholarly publication for which that person’s contribution did not justify assigning authorship. This behavior has become commonplace.
{"title":"Inappropriate Journal Authorship.","authors":"Marshall A Lichtman","doi":"10.5041/RMMJ.10513","DOIUrl":"10.5041/RMMJ.10513","url":null,"abstract":"In their article “Authorship Disputes in Scholarly Biomedical Publications and Trust in the Research Institution” in the July 2023 issue of RMMJ, Ashkenazi and Olsha examined the association between the prevalence of misattributed authorship and trust in the institution analyzing misconduct in their scholarly publications. The authors, appropriately, include “gift authorship” as one of the three principal deviations from appropriate authorship choices that they examined. In essence, gift or honorary authorship is listing an author on a scholarly publication for which that person’s contribution did not justify assigning authorship. This behavior has become commonplace.","PeriodicalId":46408,"journal":{"name":"Rambam Maimonides Medical Journal","volume":"14 4","pages":""},"PeriodicalIF":1.5,"publicationDate":"2023-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619992/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71427812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Jewish Hospitals in 20th Century Amsterdam: A Tale of Growth, Change, and Decline. 20世纪阿姆斯特丹的犹太医院:成长、变化和衰落的故事。
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-10-29 DOI: 10.5041/RMMJ.10512
Jack Y Vanderhoek

Major improvements in medical diagnostics and treatments in Dutch hospital care during the second half of the 19th century led to a shift from a nearly exclusive focus on indigent patients to an increasing proportion of hospital beds dedicated to paying middle-class patients. To accommodate this change, three private non-sectarian hospitals for middle-class patients were established in Amsterdam between 1857 and 1902. However, the two Jewish hospitals in the Dutch capital, the Dutch Jewish Ashkenazi hospital (NIZ), and the Portuguese Jewish hospital (PIZ), initially established exclusively for poor Jews, were much slower to respond to the trend of increasing hospital care for the middle class. This study examines how these hospitals addressed the needs of both poor and middle-class patients in the first decades of the 20th century as well as the success of the Centrale Israelitische Ziekenverpleging (CIZ, Central Jewish hospital) that was established solely for middle-class Jewish patients. The report also investigates how, after the devastation of the Amsterdam Jewish community during WW2, the CIZ managed to remain and today is the only ritually observant Jewish hospital unit in the Netherlands.

19世纪下半叶,荷兰医院医疗诊断和治疗的重大改进导致了从几乎只关注贫困患者转变为越来越多的病床用于支付中产阶级患者的费用。为了适应这种变化,1857年至1902年间,阿姆斯特丹为中产阶级患者建立了三家私立非宗派医院。然而,荷兰首都的两家犹太医院,荷兰犹太阿什肯纳兹医院(NIZ)和葡萄牙犹太医院(PIZ),最初专门为贫困犹太人建立,对增加中产阶级医院护理的趋势反应要慢得多。这项研究考察了这些医院在20世纪头几十年是如何满足穷人和中产阶级患者的需求的,以及专门为中产阶级犹太患者建立的以色列中央医院(CIZ,中央犹太医院)的成功。该报告还调查了在二战期间阿姆斯特丹犹太社区遭受破坏后,CIZ是如何设法保留下来的,如今它是荷兰唯一一家遵守仪式的犹太医院。
{"title":"Jewish Hospitals in 20th Century Amsterdam: A Tale of Growth, Change, and Decline.","authors":"Jack Y Vanderhoek","doi":"10.5041/RMMJ.10512","DOIUrl":"10.5041/RMMJ.10512","url":null,"abstract":"<p><p>Major improvements in medical diagnostics and treatments in Dutch hospital care during the second half of the 19th century led to a shift from a nearly exclusive focus on indigent patients to an increasing proportion of hospital beds dedicated to paying middle-class patients. To accommodate this change, three private non-sectarian hospitals for middle-class patients were established in Amsterdam between 1857 and 1902. However, the two Jewish hospitals in the Dutch capital, the Dutch Jewish Ashkenazi hospital (NIZ), and the Portuguese Jewish hospital (PIZ), initially established exclusively for poor Jews, were much slower to respond to the trend of increasing hospital care for the middle class. This study examines how these hospitals addressed the needs of both poor and middle-class patients in the first decades of the 20th century as well as the success of the Centrale Israelitische Ziekenverpleging (CIZ, Central Jewish hospital) that was established solely for middle-class Jewish patients. The report also investigates how, after the devastation of the Amsterdam Jewish community during WW2, the CIZ managed to remain and today is the only ritually observant Jewish hospital unit in the Netherlands.</p>","PeriodicalId":46408,"journal":{"name":"Rambam Maimonides Medical Journal","volume":"14 4","pages":""},"PeriodicalIF":1.5,"publicationDate":"2023-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619991/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71427813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Jewish Perspectives on Xenotransplantation. 犹太人对异种移植的看法。
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-10-29 DOI: 10.5041/RMMJ.10511
John D Loike, Rabbi Moshe Krupka

Xenotransplantation represents a viable solution to meet the great need to provide organ donors at a time when there are not enough human organ donors. A lot of clinical studies have focused on using genetically engineered pigs as the prime source for organ transplantation. However, several religions, such as Judaism and Islam, have restrictions on the use of pigs for food or in business. In this article, we review the Jewish perspectives on xenotransplantation. Overall, the preservation of human life trumps most of the potential religious concerns associated with xenotransplantation. However, there are religious nuances related to xenotransplantation that are highlighted here, and that must be addressed by rabbinical scholars.

异种移植是一种可行的解决方案,可以在没有足够的人体器官捐献者的情况下满足提供器官捐献者的巨大需求。许多临床研究都集中在使用基因工程猪作为器官移植的主要来源。然而,犹太教和伊斯兰教等一些宗教对使用猪作为食物或商业活动有限制。在这篇文章中,我们回顾了犹太人对异种移植的看法。总的来说,保护人类生命胜过与异种移植相关的大多数潜在宗教问题。然而,这里强调了与异种移植有关的宗教细微差别,拉比学者必须解决这一问题。
{"title":"The Jewish Perspectives on Xenotransplantation.","authors":"John D Loike,&nbsp;Rabbi Moshe Krupka","doi":"10.5041/RMMJ.10511","DOIUrl":"10.5041/RMMJ.10511","url":null,"abstract":"<p><p>Xenotransplantation represents a viable solution to meet the great need to provide organ donors at a time when there are not enough human organ donors. A lot of clinical studies have focused on using genetically engineered pigs as the prime source for organ transplantation. However, several religions, such as Judaism and Islam, have restrictions on the use of pigs for food or in business. In this article, we review the Jewish perspectives on xenotransplantation. Overall, the preservation of human life trumps most of the potential religious concerns associated with xenotransplantation. However, there are religious nuances related to xenotransplantation that are highlighted here, and that must be addressed by rabbinical scholars.</p>","PeriodicalId":46408,"journal":{"name":"Rambam Maimonides Medical Journal","volume":"14 4","pages":""},"PeriodicalIF":1.5,"publicationDate":"2023-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619987/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71427815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inappropriate Journal Authorship, Disputes, Plagiarism, and Mistrust in the Institution: Different Beasts ... Same Problem. 不恰当的期刊作者、争议、剽窃和机构中的不信任:不同的野兽。。。同样的问题。
IF 1.4 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-10-29 DOI: 10.5041/RMMJ.10514
Itamar Ashkenazi, Oded Olsha
{"title":"Inappropriate Journal Authorship, Disputes, Plagiarism, and Mistrust in the Institution: Different Beasts ... Same Problem.","authors":"Itamar Ashkenazi, Oded Olsha","doi":"10.5041/RMMJ.10514","DOIUrl":"10.5041/RMMJ.10514","url":null,"abstract":"","PeriodicalId":46408,"journal":{"name":"Rambam Maimonides Medical Journal","volume":"14 4","pages":""},"PeriodicalIF":1.4,"publicationDate":"2023-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619989/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71427811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biomarkers in Body Fluids as Indicators of Skeletal Maturity: A Systematic Review and Meta-analysis. 体液中的生物标志物作为骨骼成熟度的指标:系统综述和荟萃分析。
IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2023-08-30 DOI: 10.5041/RMMJ.10506
Priyanka Kapoor, Rajiv Balachandran, Aman Chowdhry, Giuseppe Perinetti, Om Prakash Kharbanda

Objectives: This review aimed to critically appraise the evidence for biomarkers in blood serum, gingival crevicular fluid (GCF), saliva, and urine in comparison with standard radiographic indices for skeletal maturation assessment.

Materials and methods: A thorough literature search in multiple databases was conducted for biomarkers in body fluids for skeletal maturation assessed with cervical vertebrae in lateral cephalograms or on hand-wrist radiographs. Different combinations including free text, MeSH terms, and Boolean operators were used. Two researchers used strict inclusion and exclusion criteria to screen title, abstract, and full text, and used the Quality Assessment of Diagnostic Accuracy Studies (QUADAS)-2 instrument for risk of bias assessment of individual studies. Meta-analysis was performed on eligible studies using RevMan 5 software.

Results: A total of 344 articles were screened, of which 33 met the inclusion criteria and quality assessment. The skeletal maturity indicators included insulin-like growth factors (IGF-1), alkaline phosphatase (ALP), bone-specific alkaline phosphatase (BALP), dehydroepiandrosterone sulfate (DHEAS), vitamin D binding protein (DBP), parathormone-related protein (PTHrP), osteocalcin, metalloproteins, and serotransferrin (TF) along with different metabolites. At puberty, a significant rise was seen in IGF-1, DBP, ALP, osteocalcin, TF, and BALP. However, the serum DHEAS and PTHrP increased from pre-pubertal to post-pubertal stages. Due to the data heterogeneity, a meta-analysis could be performed on seven studies in total on IGF-1 in serum and blood. Of these, five were included for data in males and six in females, and four studies on IGF-1 in serum and blood. A significant difference in IGF-1 levels was seen between stages of peak pubertal growth spurt (CS3 and CS4) and decelerating pubertal growth (CS5) compared with growth initiation stage (CS2).

Conclusions: Pubertal growth spurts were correlated with peak serum IGF-1 and BALP in both sexes individually. Peak ALP levels in GCF were correlated with the pubertal spurt in a combined sample of males and females. Standard biofluid collection protocols and homogeneity in sampling and methodology are strongly recommended for future research.

目的:本综述旨在批判性地评估血清、龈沟液(GCF)、唾液和尿液中生物标志物的证据,并与骨骼成熟评估的标准放射学指标进行比较。材料和方法:在多个数据库中进行了全面的文献检索,以寻找体液中用于骨骼成熟的生物标志物,这些生物标志物在侧位头影或腕关节X线片中用颈椎进行评估。使用了包括自由文本、MeSH术语和布尔运算符在内的不同组合。两名研究人员使用严格的纳入和排除标准筛选标题、摘要和全文,并使用诊断准确性研究质量评估(QUADAS)-2工具对个别研究的偏倚风险进行评估。使用RevMan 5软件对符合条件的研究进行荟萃分析。结果:共筛选出344篇文章,其中33篇符合纳入标准和质量评价。骨骼成熟度指标包括胰岛素样生长因子(IGF-1)、碱性磷酸酶(ALP)、骨特异性碱性磷酸酶(BALP)、脱氢表雄酮硫酸酯(DHEAS)、维生素D结合蛋白(DBP)、甲状旁腺相关蛋白(PTHrP)、骨钙素、金属蛋白和血清转铁蛋白(TF)以及不同的代谢产物。在青春期,IGF-1、DBP、ALP、骨钙素、TF和BALP显著升高。然而,从青春期前到青春期后,血清DHEAS和PTHrP增加。由于数据的异质性,可以对血清和血液中IGF-1的总共7项研究进行荟萃分析。其中,5项为男性数据,6项为女性数据,4项为血清和血液中IGF-1的研究。与生长起始期(CS2)相比,青春期生长高峰期(CS3和CS4)和青春期生长减速期(CS5)的IGF-1水平存在显著差异。在男性和女性的联合样本中,GCF中的ALP峰值水平与青春期爆发有关。强烈建议未来的研究采用标准的生物流体收集方案以及采样和方法的同质性。
{"title":"Biomarkers in Body Fluids as Indicators of Skeletal Maturity: A Systematic Review and Meta-analysis.","authors":"Priyanka Kapoor,&nbsp;Rajiv Balachandran,&nbsp;Aman Chowdhry,&nbsp;Giuseppe Perinetti,&nbsp;Om Prakash Kharbanda","doi":"10.5041/RMMJ.10506","DOIUrl":"10.5041/RMMJ.10506","url":null,"abstract":"<p><strong>Objectives: </strong>This review aimed to critically appraise the evidence for biomarkers in blood serum, gingival crevicular fluid (GCF), saliva, and urine in comparison with standard radiographic indices for skeletal maturation assessment.</p><p><strong>Materials and methods: </strong>A thorough literature search in multiple databases was conducted for biomarkers in body fluids for skeletal maturation assessed with cervical vertebrae in lateral cephalograms or on hand-wrist radiographs. Different combinations including free text, MeSH terms, and Boolean operators were used. Two researchers used strict inclusion and exclusion criteria to screen title, abstract, and full text, and used the Quality Assessment of Diagnostic Accuracy Studies (QUADAS)-2 instrument for risk of bias assessment of individual studies. Meta-analysis was performed on eligible studies using RevMan 5 software.</p><p><strong>Results: </strong>A total of 344 articles were screened, of which 33 met the inclusion criteria and quality assessment. The skeletal maturity indicators included insulin-like growth factors (IGF-1), alkaline phosphatase (ALP), bone-specific alkaline phosphatase (BALP), dehydroepiandrosterone sulfate (DHEAS), vitamin D binding protein (DBP), parathormone-related protein (PTHrP), osteocalcin, metalloproteins, and serotransferrin (TF) along with different metabolites. At puberty, a significant rise was seen in IGF-1, DBP, ALP, osteocalcin, TF, and BALP. However, the serum DHEAS and PTHrP increased from pre-pubertal to post-pubertal stages. Due to the data heterogeneity, a meta-analysis could be performed on seven studies in total on IGF-1 in serum and blood. Of these, five were included for data in males and six in females, and four studies on IGF-1 in serum and blood. A significant difference in IGF-1 levels was seen between stages of peak pubertal growth spurt (CS3 and CS4) and decelerating pubertal growth (CS5) compared with growth initiation stage (CS2).</p><p><strong>Conclusions: </strong>Pubertal growth spurts were correlated with peak serum IGF-1 and BALP in both sexes individually. Peak ALP levels in GCF were correlated with the pubertal spurt in a combined sample of males and females. Standard biofluid collection protocols and homogeneity in sampling and methodology are strongly recommended for future research.</p>","PeriodicalId":46408,"journal":{"name":"Rambam Maimonides Medical Journal","volume":" ","pages":""},"PeriodicalIF":1.5,"publicationDate":"2023-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619988/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10164362","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Rambam Maimonides Medical Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1